Mostafa Kamal

Mostafa Kamal serves as the President and Chief Executive Officer of Prime Therapeutics since March 2023. Prior to this role, Mostafa held several leadership positions at Magellan Rx Management from December 2011 to September 2024, including Chief Executive Officer and Senior Vice President & General Manager of Magellan Rx Specialty. Mostafa also worked at Express Scripts from September 2007 to December 2011, focusing on strategy, pricing, and analytics. Earlier experience includes roles in pricing strategy at Hertz and Cendant Corporation. Mostafa Kamal earned a Bachelor of Science degree in Business Economics from Rutgers University.